This online course provides a review of the epidemiology and risk factors, screening and treatment of colorectal cancer. Participants will review a case from initial presentation for a routine visit to their general internists to screening to work-up and treatment.

NUMBER OF CREDIT HOURS: The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

COST: $40.00
click here for pricing outside the United States of America

OVERALL LEARNING OBJECTIVES:

1. Review risk factors and screening guidelines for colorectal cancer.

CLINICAL LEARNING OBJECTIVES:

1. Review work-up and staging for patients with colorectal cancer.
2. Review treatment options for patients with colorectal cancer, depending on stage of disease.
3. Review follow-up surveillance of colorectal cancer survivors.

back to the top

JEFFREY MEYERHARDT, MD, MPH Course Director

Dr. Meyerhardt is an Associate Physician of the Department of Medical Oncology at the Dana-Farber Cancer Institute, member of the Gastrointestinal Cancer Center and Assistant Professor of Medicine at Harvard Medical School. Dr. Meyerhardt conducts outcomes research in patients with gastrointestinal cancer, particularly the relationship between diet and lifestyle on patients with colorectal cancer. In addition, he has served as lead investigator and co-investigator of multiple clinical trials for patients with gastrointestinal cancers. Dr. Meyerhardt received his undergraduate degree from Haverford College, medical degree at Yale School of Medicine and Masters of Public Health at the Harvard School of Public Health. DISCLOSURE: Sanofi-aventis: Consultant (<10 K/year): Treatment

back to the top

PETER C. ENZINGER, MD Reviewer

Bio and Photo Coming Soon. DISCLOSURE:

ROBERT MAYER, MD Reviewer

Dr. Mayer is Vice Chair for Academic Affairs of the Department of Medical Oncology at the Dana-Farber Cancer Institute, Senior Physician at the Brigham and Women's Hospital, Physician at the Massachusetts General Hospital, and the Stephen B. Kay Professor of Medicine at the Harvard Medical School where he is also Faculty Associate Dean for Admissions. He has directed the Institute's Medical Oncology Training Program since 1975 and is presently the Director of the Hematology/Oncology Fellowship Program of Dana-Farber/Partners CancerCare. Dr. Mayer's research interests focus on gastrointestinal cancer a subject about which he has published extensively. Dr. Mayer established the Center for Gastrointestinal Oncology at the Dana-Farber Cancer Institute and is the past Chair of the Gastrointestinal Cancer Committee of the Cancer and Leukemia Group B, a cooperative group sponsored by the National Cancer Institute. He has served as an Associate Editor for the New England Journal of Medicine, is a past President of the American Society of Clinical Oncology and the Association of Subspecialty Professors and is a former member of the Executive Committee of the American Board of Internal Medicine. Dr. Mayer is a graduate of Williams College and the Harvard Medical School. DISCLOSURE:

DAVID P. RYAN, MD Reviewer

Bio and Photo Coming Soon. DISCLOSURE:

ANDREW ZHU, MD, PHD Reviewer

Dr. Andrew X. Zhu is an attending Oncologist at Massachusetts General Hospital Cancer Center, a Staff Physician at Dana-Farber Cancer Institute, and a Member of Dana-Farber Harvard Cancer Center in Boston, Mass. He is also an Assistant Professor of Medicine at Harvard Medical School. Dr. Zhu is board-certified in internal medicine and medical oncology, and holds clinical research interests in developing novel treatments for gastrointestinal cancers including hepatocellular carcinoma, bile duct tumor, and colorectal cancer. Dr. Zhu received his medical degree from Beijing Medical University in China and his doctor of philosophy in microbiology from Columbia University in New York City. He completed his internship and residency in internal medicine at the University of Minnesota Hospitals and Clinics and Yale-New Haven Hospital. After a fellowship in molecular biology at Harvard Medical School, he was a Mortimer Lacher Fellow in medical oncology at Memorial Sloan-Kettering Cancer Center in New York City. As a widely published author, Dr. Zhu has served as principle investigator in many clinical trials in hepatobiliary and colorectal cancers and has published papers on many leading journals including the New England Journal of Medicine, Journal of Clinical Oncology, Clinical Cancer Research, and Cancer. He is a founding board member of the International Liver Cancer Association and a member of the American Society of Clinical Oncology, the American College of Physicians, and the American Association for Cancer Research. DISCLOSURE:

back to the top

NUMBER OF CREDITS: 2 

Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Upon completion of the course you will get a certificate via e-mail within 2 weeks.

Click the image to view a sample of the certificate

back to the top